Maggie Lee

This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Eukaryotic Genome Modification. Top assignees: Dna Twopointo Inc., Dna2.0, Inc., The General Hospital Corporation. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maggie Lee. Retrieved from https://idiyas.com/inventor/maggie-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 79(Granted Patents)

Company Filing History:

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Constructs

Transposase

Eukaryotic Cells

Gene Expression

CAR-T Cells

Artificial Micro-RNA

Transposons

Genome Modification

DNA Vectors

Mammalian Cells

Transposition

Eukaryotic Genomes

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12742171 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2026-09-22),

2. 12612646 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2026-04-28),

3. 12590319 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2026-03-31),

4. 12419913 - Modification of CAR-T cells (2025-09-23),

5. 12404504 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis (2025-09-02),

6. 12351800 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2025-07-08),

7. 12122995 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-10-22),

8. 12054702 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-08-06),

9. 11845936 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2023-12-19),

10. 11713468 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2023-08-01),

11. 11401521 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2022-08-02),

12. 11396662 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2022-07-26),

13. 11162102 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2021-11-02),

14. 11060109 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2021-07-13),

15. 11060098 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2021-07-13),

Title: Inventor Maggie Lee: Revolutionizing Technology in San Jose

Introduction: Maggie Lee is a pioneering inventor based in San Jose, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Maggie Lee holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing her commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Maggie Lee has worked with top tech companies in Silicon Valley, leading research and development teams to create cutting-edge solutions that have transformed industries.

Collaborations: Throughout her career, Maggie Lee has collaborated with renowned scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge-sharing in the tech community.

Conclusion: Maggie Lee's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, solidifying her legacy as a true trailblazer in the world of technology.

Profile summary based on public USPTO records.